Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status

Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data

(2015) Edwin Wang et al.   SEMINARS IN CANCER BIOLOGY

Circulating metastasis associated in colon cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker

(2015) Susen Burock   WORLD JOURNAL OF GASTROENTEROLOGY

Defining hierarchies of stemness in the intestine: evidence from biomarkers and regulatory pathways

(2014) A. D. Gracz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors

(2014) Mark Kidd et al.   BMC GENOMICS

Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment

(2014) Annemiek Walenkamp et al.   ENDOCRINE-RELATED CANCER

A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection

(2014) Irvin M Modlin et al.   ENDOCRINE-RELATED CANCER

Neuroendocrine Tumor Biomarkers: Current Status and Perspectives

(2014) Irvin M. Modlin et al.   NEUROENDOCRINOLOGY

Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia

(2014) Li Zhang et al.   PEDIATRIC BLOOD & CANCER

A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases

(2014) Simon Schimmack et al.   Epigenetics & Chromatin

p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors

(2014) Hee Sung Kim et al.   Cancer Research and Treatment

A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors

(2014) Irvin M Modlin et al.   Endocrine Connections

A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells

(2013) Martin Grimm et al.   BMC CANCER

The prognostic value of apoptotic and proliferative markers in breast cancer

(2013) Charla C. Engels et al.   BREAST CANCER RESEARCH AND TREATMENT

Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility

(2013) Irvin M. Modlin et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Analytic and Clinical Validation of a Prostate Cancer–Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival

(2013) Daniel C. Danila et al.   EUROPEAN UROLOGY

Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors

(2013) Ilaria Marinoni et al.   GASTROENTEROLOGY

The genomic landscape of small intestine neuroendocrine tumors

(2013) Michaela S. Banck et al.   JOURNAL OF CLINICAL INVESTIGATION

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

(2013) Joshua M Francis et al.   NATURE GENETICS

The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood

(2013) Irvin M. Modlin et al.   PLoS One

Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1

(2013) Yanan Cao et al.   Nature Communications

Limitations of Chromogranin A in clinical practice

(2012) Vincenzo Marotta et al.   BIOMARKERS

Analytical variables influencing the HCV RNA determination by TaqMan real-time PCR in routine clinical laboratory practice

(2012) Abida Raza et al.   MOLECULAR BIOLOGY REPORTS

STRING v9.1: protein-protein interaction networks, with increased coverage and integration

(2012) Andrea Franceschini et al.   NUCLEIC ACIDS RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors

(2011) Ben Lawrence et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Neuroendocrine neoplasms of the gut and pancreas: new insights

(2011) Guido Rindi et al.   Nature Reviews Endocrinology

Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients

(2011) Lucia Anna Muscarella et al.   CELLULAR ONCOLOGY

A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis

(2010) Humam Kadara et al.   CLINICAL CANCER RESEARCH

Entrez Gene: gene-centered information at NCBI

(2010) D. Maglott et al.   NUCLEIC ACIDS RESEARCH

Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors

(2010) Tao Cui et al.   PLoS One

Stability and aggregation of ranked gene lists

(2009) A.-L. Boulesteix et al.   BRIEFINGS IN BIOINFORMATICS

Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning

(2009) Ignat Drozdov et al.   CANCER

Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant  -Catenin Activation in Colon Cancer

(2009) S. Naik et al.   CLINICAL CANCER RESEARCH

arrayQualityMetrics—a bioconductor package for quality assessment of microarray data

(2008) Audrey Kauffmann et al.   BIOINFORMATICS

ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

(2008) M. D. Hogarty et al.   CANCER RESEARCH

Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas

(2008) Justyna Leja et al.   MODERN PATHOLOGY

A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging

(2008) Silvia Miretti et al.   PLoS One